These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 14733956)

  • 1. Eotaxin and monocyte chemotactic protein-3 use different modes of action.
    Chung IY; Kim YH; Choi MK; Noh YJ; Park CS; Kwon DY; Lee DY; Lee YS; Chang HS; Kim KS
    Biochem Biophys Res Commun; 2004 Feb; 314(2):646-53. PubMed ID: 14733956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cloning and functional characterization of a novel human CC chemokine that binds to the CCR3 receptor and activates human eosinophils.
    White JR; Imburgia C; Dul E; Appelbaum E; O'Donnell K; O'Shannessy DJ; Brawner M; Fornwald J; Adamou J; Elshourbagy NA; Kaiser K; Foley JJ; Schmidt DB; Johanson K; Macphee C; Moores K; McNulty D; Scott GF; Schleimer RP; Sarau HM
    J Leukoc Biol; 1997 Nov; 62(5):667-75. PubMed ID: 9365122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage-derived chemokine induces human eosinophil chemotaxis in a CC chemokine receptor 3- and CC chemokine receptor 4-independent manner.
    Bochner BS; Bickel CA; Taylor ML; MacGlashan DW; Gray PW; Raport CJ; Godiska R
    J Allergy Clin Immunol; 1999 Mar; 103(3 Pt 1):527-32. PubMed ID: 10069890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor reserve analysis of the human CCR3 receptor in eosinophils and CCR3-transfected cells.
    Umland SP; Wan Y; Shortall J; Shah H; Jakway J; Garlisi CG; Tian F; Egan RW; Billah MM
    J Leukoc Biol; 2000 Mar; 67(3):441-7. PubMed ID: 10733106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of potent, selective non-peptide CC chemokine receptor-3 antagonist that inhibits eotaxin-, eotaxin-2-, and monocyte chemotactic protein-4-induced eosinophil migration.
    White JR; Lee JM; Dede K; Imburgia CS; Jurewicz AJ; Chan G; Fornwald JA; Dhanak D; Christmann LT; Darcy MG; Widdowson KL; Foley JJ; Schmidt DB; Sarau HM
    J Biol Chem; 2000 Nov; 275(47):36626-31. PubMed ID: 10969084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines.
    Uguccioni M; Mackay CR; Ochensberger B; Loetscher P; Rhis S; LaRosa GJ; Rao P; Ponath PD; Baggiolini M; Dahinden CA
    J Clin Invest; 1997 Sep; 100(5):1137-43. PubMed ID: 9276730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-C chemokines in allergen-induced late-phase cutaneous responses in atopic subjects: association of eotaxin with early 6-hour eosinophils, and of eotaxin-2 and monocyte chemoattractant protein-4 with the later 24-hour tissue eosinophilia, and relationship to basophils and other C-C chemokines (monocyte chemoattractant protein-3 and RANTES).
    Ying S; Robinson DS; Meng Q; Barata LT; McEuen AR; Buckley MG; Walls AF; Askenase PW; Kay AB
    J Immunol; 1999 Oct; 163(7):3976-84. PubMed ID: 10491000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody.
    Heath H; Qin S; Rao P; Wu L; LaRosa G; Kassam N; Ponath PD; Mackay CR
    J Clin Invest; 1997 Jan; 99(2):178-84. PubMed ID: 9005985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils.
    Ponath PD; Qin S; Ringler DJ; Clark-Lewis I; Wang J; Kassam N; Smith H; Shi X; Gonzalo JA; Newman W; Gutierrez-Ramos JC; Mackay CR
    J Clin Invest; 1996 Feb; 97(3):604-12. PubMed ID: 8609214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning, expression, and characterization of the human eosinophil eotaxin receptor.
    Daugherty BL; Siciliano SJ; DeMartino JA; Malkowitz L; Sirotina A; Springer MS
    J Exp Med; 1996 May; 183(5):2349-54. PubMed ID: 8642344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils.
    Ponath PD; Qin S; Post TW; Wang J; Wu L; Gerard NP; Newman W; Gerard C; Mackay CR
    J Exp Med; 1996 Jun; 183(6):2437-48. PubMed ID: 8676064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of the novel C-C chemokine MCP-4 by airway cells and comparison of its biological activity to other C-C chemokines.
    Stellato C; Collins P; Ponath PD; Soler D; Newman W; La Rosa G; Li H; White J; Schwiebert LM; Bickel C; Liu M; Bochner BS; Williams T; Schleimer RP
    J Clin Invest; 1997 Mar; 99(5):926-36. PubMed ID: 9062350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ligands of CXC chemokine receptor 3, I-TAC, Mig, and IP10, are natural antagonists for CCR3.
    Loetscher P; Pellegrino A; Gong JH; Mattioli I; Loetscher M; Bardi G; Baggiolini M; Clark-Lewis I
    J Biol Chem; 2001 Feb; 276(5):2986-91. PubMed ID: 11110785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High level expression, activation, and antagonism of CC chemokine receptors CCR2 and CCR3 in Chinese hamster ovary cells.
    Parody TR; Stone MJ
    Cytokine; 2004 Jul; 27(1):38-46. PubMed ID: 15207250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Migration of eosinophils across endothelial cell monolayers: interactions among IL-5, endothelial-activating cytokines, and C-C chemokines.
    Shahabuddin S; Ponath P; Schleimer RP
    J Immunol; 2000 Apr; 164(7):3847-54. PubMed ID: 10725746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human RANTES acts as a receptor antagonist for guinea pig eotaxin in vitro and in vivo.
    Marleau S; Griffiths-Johnson DA; Collins PD; Bakhle YS; Williams TJ; Jose PJ
    J Immunol; 1996 Nov; 157(9):4141-6. PubMed ID: 8892650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential regulation of eosinophil chemokine signaling via CCR3 and non-CCR3 pathways.
    Sabroe I; Hartnell A; Jopling LA; Bel S; Ponath PD; Pease JE; Collins PD; Williams TJ
    J Immunol; 1999 Mar; 162(5):2946-55. PubMed ID: 10072545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning and characterization of the guinea pig eosinophil eotaxin receptor, C-C chemokine receptor-3: blockade using a monoclonal antibody in vivo.
    Sabroe I; Conroy DM; Gerard NP; Li Y; Collins PD; Post TW; Jose PJ; Williams TJ; Gerard CJ; Ponath PD
    J Immunol; 1998 Dec; 161(11):6139-47. PubMed ID: 9834099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The N-terminal extracellular segments of the chemokine receptors CCR1 and CCR3 are determinants for MIP-1alpha and eotaxin binding, respectively, but a second domain is essential for efficient receptor activation.
    Pease JE; Wang J; Ponath PD; Murphy PM
    J Biol Chem; 1998 Aug; 273(32):19972-6. PubMed ID: 9685332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemokine-binding specificity of soluble chemokine-receptor analogues: identification of interacting elements by chimera complementation.
    Datta-Mannan A; Stone MJ
    Biochemistry; 2004 Nov; 43(46):14602-11. PubMed ID: 15544331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.